Skip to content
Clinical Trials – home

Universita' Politecnica Delle Marche

Research site

Italy Via Conca 71, 60126 Ancona, Italy

  • 125 trials recruiting
  • Plasma cell myeloma · Breast cancer · Hidradenitis
  • Adults and children

About Specializations

Universita' Politecnica Delle Marche in Ancona, Italy specialises in clinical trials of conditions such as Plasma cell myeloma, Breast cancer, Hidradenitis, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases and Musculoskeletal Diseases

At Universita' Politecnica Delle Marche, clinical research in this area focuses on the overlap between immune system disorders and muscle-related conditions, with particular attention to polymyositis and dermatomyositis. The studies are designed to better understand disease activity and assess whether new treatment approaches can improve patient outcomes.

  • Exploring treatment options for idiopathic inflammatory myopathies
  • Evaluating the impact of anifrolumab compared with placebo alongside standard care
  • Assessing improvement in disease activity for adults with polymyositis and dermatomyositis

This work reflects a focused effort in clinical immunology and rheumatology, aiming to support more effective care for people living with these rare inflammatory diseases.

Immune System Phenomena and Musculoskeletal and Neural Physiological Phenomena

The research portfolio also examines key immune system processes and their effects on muscle function and related physiological changes. Conducted at the Department of Molecular and Clinical Sciences, these trials contribute to a better understanding of how inflammation influences disease progression and treatment response.

  • Studying immune-mediated inflammation in inflammatory myopathies
  • Investigating how therapy may improve musculoskeletal symptoms
  • Supporting research into more precise disease control for affected adults

With a small but targeted trial base and broad investigator involvement, the site is building knowledge around autoimmune muscle disease and practical ways to measure treatment benefit.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Conca 7160126 AnconaItaly
Recruiting now
125 trials
Conditions studied
175

More sites in AnconaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

311 clinical trials

A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Hidradenitis

Recruiting

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Renal disorder

Recruiting

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Asthma

Recruiting

Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Breast cancer

Recruiting

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE

Vitiligo+2

Recruiting

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.